nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—ABCB1—esophageal cancer	0.449	1	CbGaD
Pimozide—HTR2A—vagus nerve—esophageal cancer	0.00681	0.092	CbGeAlD
Pimozide—CACNA1G—digestive system—esophageal cancer	0.00389	0.0525	CbGeAlD
Pimozide—CALM2—exocrine gland—esophageal cancer	0.00386	0.0521	CbGeAlD
Pimozide—CALM1—exocrine gland—esophageal cancer	0.00384	0.0518	CbGeAlD
Pimozide—Ezetimibe—ABCC2—esophageal cancer	0.00308	0.355	CrCbGaD
Pimozide—CALM2—neck—esophageal cancer	0.00246	0.0333	CbGeAlD
Pimozide—CALM1—neck—esophageal cancer	0.00245	0.0331	CbGeAlD
Pimozide—CALM3—bronchus—esophageal cancer	0.0021	0.0284	CbGeAlD
Pimozide—CALM3—smooth muscle tissue—esophageal cancer	0.00206	0.0278	CbGeAlD
Pimozide—CALM3—trachea—esophageal cancer	0.00189	0.0255	CbGeAlD
Pimozide—Flunarizine—CYP2A6—esophageal cancer	0.00179	0.206	CrCbGaD
Pimozide—CALM2—epithelium—esophageal cancer	0.00168	0.0226	CbGeAlD
Pimozide—CALM1—epithelium—esophageal cancer	0.00167	0.0225	CbGeAlD
Pimozide—CALM2—bronchus—esophageal cancer	0.00165	0.0223	CbGeAlD
Pimozide—CALM1—bronchus—esophageal cancer	0.00164	0.0222	CbGeAlD
Pimozide—CALM2—smooth muscle tissue—esophageal cancer	0.00162	0.0218	CbGeAlD
Pimozide—CALM1—smooth muscle tissue—esophageal cancer	0.00161	0.0217	CbGeAlD
Pimozide—HTR2A—neck—esophageal cancer	0.00149	0.0202	CbGeAlD
Pimozide—CALM2—trachea—esophageal cancer	0.00148	0.02	CbGeAlD
Pimozide—CALM1—trachea—esophageal cancer	0.00148	0.0199	CbGeAlD
Pimozide—CALM3—lung—esophageal cancer	0.00136	0.0183	CbGeAlD
Pimozide—CALM2—digestive system—esophageal cancer	0.00128	0.0172	CbGeAlD
Pimozide—CALM1—digestive system—esophageal cancer	0.00127	0.0172	CbGeAlD
Pimozide—HRH1—epithelium—esophageal cancer	0.00122	0.0164	CbGeAlD
Pimozide—CYP2C19—digestive system—esophageal cancer	0.00121	0.0164	CbGeAlD
Pimozide—HRH1—smooth muscle tissue—esophageal cancer	0.00117	0.0158	CbGeAlD
Pimozide—Ezetimibe—ABCB1—esophageal cancer	0.00113	0.13	CrCbGaD
Pimozide—Astemizole—ABCB1—esophageal cancer	0.00113	0.13	CrCbGaD
Pimozide—HRH1—trachea—esophageal cancer	0.00108	0.0145	CbGeAlD
Pimozide—CALM2—lung—esophageal cancer	0.00107	0.0144	CbGeAlD
Pimozide—CALM1—lung—esophageal cancer	0.00106	0.0143	CbGeAlD
Pimozide—Loss of libido—Methotrexate—esophageal cancer	0.00103	0.0254	CcSEcCtD
Pimozide—HTR2A—epithelium—esophageal cancer	0.00102	0.0137	CbGeAlD
Pimozide—CYP1A2—digestive system—esophageal cancer	0.00099	0.0134	CbGeAlD
Pimozide—HTR2A—smooth muscle tissue—esophageal cancer	0.00098	0.0132	CbGeAlD
Pimozide—DRD2—lung—esophageal cancer	0.00098	0.0132	CbGeAlD
Pimozide—CYP3A5—digestive system—esophageal cancer	0.000954	0.0129	CbGeAlD
Pimozide—CALM3—lymph node—esophageal cancer	0.000928	0.0125	CbGeAlD
Pimozide—HRH1—digestive system—esophageal cancer	0.000926	0.0125	CbGeAlD
Pimozide—Nuchal rigidity—Methotrexate—esophageal cancer	0.000917	0.0226	CcSEcCtD
Pimozide—Torsade de pointes—Capecitabine—esophageal cancer	0.000911	0.0224	CcSEcCtD
Pimozide—HTR2A—trachea—esophageal cancer	0.000899	0.0121	CbGeAlD
Pimozide—CYP2E1—digestive system—esophageal cancer	0.00089	0.012	CbGeAlD
Pimozide—Ventricular fibrillation—Capecitabine—esophageal cancer	0.000834	0.0205	CcSEcCtD
Pimozide—CYP1A2—lung—esophageal cancer	0.000826	0.0112	CbGeAlD
Pimozide—Fexofenadine—ABCB1—esophageal cancer	0.000806	0.093	CrCbGaD
Pimozide—CYP3A5—lung—esophageal cancer	0.000797	0.0108	CbGeAlD
Pimozide—HTR2A—digestive system—esophageal cancer	0.000774	0.0104	CbGeAlD
Pimozide—HRH1—lung—esophageal cancer	0.000774	0.0104	CbGeAlD
Pimozide—CYP2E1—lung—esophageal cancer	0.000743	0.01	CbGeAlD
Pimozide—Domperidone—ABCB1—esophageal cancer	0.000736	0.0848	CrCbGaD
Pimozide—CALM2—lymph node—esophageal cancer	0.000729	0.00984	CbGeAlD
Pimozide—CALM1—lymph node—esophageal cancer	0.000725	0.0098	CbGeAlD
Pimozide—CYP3A4—digestive system—esophageal cancer	0.000716	0.00967	CbGeAlD
Pimozide—CYP2D6—digestive system—esophageal cancer	0.000705	0.00952	CbGeAlD
Pimozide—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000697	0.0172	CcSEcCtD
Pimozide—Nocturia—Capecitabine—esophageal cancer	0.000689	0.017	CcSEcCtD
Pimozide—Cataract—Capecitabine—esophageal cancer	0.000671	0.0165	CcSEcCtD
Pimozide—ABCB1—epithelium—esophageal cancer	0.000666	0.009	CbGeAlD
Pimozide—KCNH2—lymph node—esophageal cancer	0.00066	0.00891	CbGeAlD
Pimozide—HTR2A—lung—esophageal cancer	0.000646	0.00873	CbGeAlD
Pimozide—Hyponatraemia—Cisplatin—esophageal cancer	0.000632	0.0156	CcSEcCtD
Pimozide—ABCB1—trachea—esophageal cancer	0.000589	0.00796	CbGeAlD
Pimozide—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000575	0.0141	CcSEcCtD
Pimozide—Breast disorder—Cisplatin—esophageal cancer	0.000568	0.014	CcSEcCtD
Pimozide—Cramp muscle—Cisplatin—esophageal cancer	0.000566	0.0139	CcSEcCtD
Pimozide—Speech disorder—Methotrexate—esophageal cancer	0.000553	0.0136	CcSEcCtD
Pimozide—HRH1—lymph node—esophageal cancer	0.000529	0.00715	CbGeAlD
Pimozide—Abdominal discomfort—Cisplatin—esophageal cancer	0.000521	0.0128	CcSEcCtD
Pimozide—Pancytopenia—Cisplatin—esophageal cancer	0.000516	0.0127	CcSEcCtD
Pimozide—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000514	0.0126	CcSEcCtD
Pimozide—ABCB1—digestive system—esophageal cancer	0.000507	0.00685	CbGeAlD
Pimozide—Increased appetite—Capecitabine—esophageal cancer	0.000494	0.0122	CcSEcCtD
Pimozide—Hyponatraemia—Capecitabine—esophageal cancer	0.000466	0.0115	CcSEcCtD
Pimozide—Aplastic anaemia—Methotrexate—esophageal cancer	0.000446	0.011	CcSEcCtD
Pimozide—Urinary retention—Capecitabine—esophageal cancer	0.000441	0.0109	CcSEcCtD
Pimozide—Connective tissue disorder—Cisplatin—esophageal cancer	0.000428	0.0105	CcSEcCtD
Pimozide—Gynaecomastia—Methotrexate—esophageal cancer	0.000425	0.0105	CcSEcCtD
Pimozide—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000424	0.0104	CcSEcCtD
Pimozide—ABCB1—lung—esophageal cancer	0.000423	0.00572	CbGeAlD
Pimozide—Visual impairment—Cisplatin—esophageal cancer	0.000419	0.0103	CcSEcCtD
Pimozide—Breast disorder—Capecitabine—esophageal cancer	0.000419	0.0103	CcSEcCtD
Pimozide—Eye disorder—Cisplatin—esophageal cancer	0.000407	0.01	CcSEcCtD
Pimozide—Cardiac disorder—Cisplatin—esophageal cancer	0.000404	0.00994	CcSEcCtD
Pimozide—Dysphagia—Capecitabine—esophageal cancer	0.000401	0.00987	CcSEcCtD
Pimozide—Abdominal discomfort—Capecitabine—esophageal cancer	0.000384	0.00946	CcSEcCtD
Pimozide—Pancytopenia—Capecitabine—esophageal cancer	0.000381	0.00937	CcSEcCtD
Pimozide—Weight increased—Capecitabine—esophageal cancer	0.000365	0.00898	CcSEcCtD
Pimozide—Visual disturbance—Methotrexate—esophageal cancer	0.000364	0.00897	CcSEcCtD
Pimozide—Muscle spasms—Cisplatin—esophageal cancer	0.000364	0.00897	CcSEcCtD
Pimozide—Weight decreased—Capecitabine—esophageal cancer	0.000363	0.00893	CcSEcCtD
Pimozide—Vision blurred—Cisplatin—esophageal cancer	0.000357	0.00879	CcSEcCtD
Pimozide—Depression—Capecitabine—esophageal cancer	0.000356	0.00877	CcSEcCtD
Pimozide—Tremor—Cisplatin—esophageal cancer	0.000355	0.00874	CcSEcCtD
Pimozide—Anaemia—Cisplatin—esophageal cancer	0.00035	0.00862	CcSEcCtD
Pimozide—Leukopenia—Cisplatin—esophageal cancer	0.000339	0.00835	CcSEcCtD
Pimozide—Agranulocytosis—Capecitabine—esophageal cancer	0.000333	0.00821	CcSEcCtD
Pimozide—Convulsion—Cisplatin—esophageal cancer	0.000328	0.00808	CcSEcCtD
Pimozide—Myalgia—Cisplatin—esophageal cancer	0.000323	0.00794	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00032	0.00789	CcSEcCtD
Pimozide—Connective tissue disorder—Capecitabine—esophageal cancer	0.000315	0.00776	CcSEcCtD
Pimozide—Breast disorder—Methotrexate—esophageal cancer	0.000312	0.00768	CcSEcCtD
Pimozide—Visual impairment—Capecitabine—esophageal cancer	0.000309	0.00761	CcSEcCtD
Pimozide—Nervous system disorder—Cisplatin—esophageal cancer	0.000303	0.00747	CcSEcCtD
Pimozide—Tachycardia—Cisplatin—esophageal cancer	0.000302	0.00743	CcSEcCtD
Pimozide—Skin disorder—Cisplatin—esophageal cancer	0.0003	0.00739	CcSEcCtD
Pimozide—Eye disorder—Capecitabine—esophageal cancer	0.0003	0.00738	CcSEcCtD
Pimozide—Hyperhidrosis—Cisplatin—esophageal cancer	0.000299	0.00736	CcSEcCtD
Pimozide—Cardiac disorder—Capecitabine—esophageal cancer	0.000298	0.00733	CcSEcCtD
Pimozide—Eosinophilia—Methotrexate—esophageal cancer	0.000295	0.00727	CcSEcCtD
Pimozide—Anorexia—Cisplatin—esophageal cancer	0.000295	0.00726	CcSEcCtD
Pimozide—ABCB1—lymph node—esophageal cancer	0.00029	0.00391	CbGeAlD
Pimozide—Hypotension—Cisplatin—esophageal cancer	0.000289	0.00711	CcSEcCtD
Pimozide—Abdominal discomfort—Methotrexate—esophageal cancer	0.000286	0.00704	CcSEcCtD
Pimozide—Pancytopenia—Methotrexate—esophageal cancer	0.000283	0.00698	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000282	0.00694	CcSEcCtD
Pimozide—Mental disorder—Capecitabine—esophageal cancer	0.000281	0.00692	CcSEcCtD
Pimozide—Erectile dysfunction—Methotrexate—esophageal cancer	0.000275	0.00677	CcSEcCtD
Pimozide—Decreased appetite—Cisplatin—esophageal cancer	0.000269	0.00662	CcSEcCtD
Pimozide—Muscle spasms—Capecitabine—esophageal cancer	0.000268	0.00661	CcSEcCtD
Pimozide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000267	0.00657	CcSEcCtD
Pimozide—Drowsiness—Methotrexate—esophageal cancer	0.000266	0.00655	CcSEcCtD
Pimozide—Depression—Methotrexate—esophageal cancer	0.000265	0.00653	CcSEcCtD
Pimozide—Vision blurred—Capecitabine—esophageal cancer	0.000263	0.00648	CcSEcCtD
Pimozide—Tremor—Capecitabine—esophageal cancer	0.000262	0.00644	CcSEcCtD
Pimozide—Anaemia—Capecitabine—esophageal cancer	0.000258	0.00635	CcSEcCtD
Pimozide—Sweating—Methotrexate—esophageal cancer	0.000255	0.00628	CcSEcCtD
Pimozide—Syncope—Capecitabine—esophageal cancer	0.00025	0.00617	CcSEcCtD
Pimozide—Leukopenia—Capecitabine—esophageal cancer	0.00025	0.00615	CcSEcCtD
Pimozide—Agranulocytosis—Methotrexate—esophageal cancer	0.000248	0.00611	CcSEcCtD
Pimozide—Palpitations—Capecitabine—esophageal cancer	0.000247	0.00608	CcSEcCtD
Pimozide—Loss of consciousness—Capecitabine—esophageal cancer	0.000245	0.00604	CcSEcCtD
Pimozide—Hypertension—Capecitabine—esophageal cancer	0.000241	0.00594	CcSEcCtD
Pimozide—Myalgia—Capecitabine—esophageal cancer	0.000238	0.00585	CcSEcCtD
Pimozide—Chest pain—Capecitabine—esophageal cancer	0.000238	0.00585	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000236	0.00581	CcSEcCtD
Pimozide—Dry mouth—Capecitabine—esophageal cancer	0.000233	0.00572	CcSEcCtD
Pimozide—Visual impairment—Methotrexate—esophageal cancer	0.00023	0.00567	CcSEcCtD
Pimozide—Shock—Capecitabine—esophageal cancer	0.000224	0.00552	CcSEcCtD
Pimozide—Nervous system disorder—Capecitabine—esophageal cancer	0.000223	0.0055	CcSEcCtD
Pimozide—Eye disorder—Methotrexate—esophageal cancer	0.000223	0.00549	CcSEcCtD
Pimozide—Tachycardia—Capecitabine—esophageal cancer	0.000222	0.00548	CcSEcCtD
Pimozide—Asthenia—Cisplatin—esophageal cancer	0.000222	0.00546	CcSEcCtD
Pimozide—Cardiac disorder—Methotrexate—esophageal cancer	0.000222	0.00546	CcSEcCtD
Pimozide—Skin disorder—Capecitabine—esophageal cancer	0.000221	0.00545	CcSEcCtD
Pimozide—Hyperhidrosis—Capecitabine—esophageal cancer	0.00022	0.00542	CcSEcCtD
Pimozide—Anorexia—Capecitabine—esophageal cancer	0.000217	0.00535	CcSEcCtD
Pimozide—Hypotension—Capecitabine—esophageal cancer	0.000213	0.00524	CcSEcCtD
Pimozide—Diarrhoea—Cisplatin—esophageal cancer	0.000212	0.00521	CcSEcCtD
Pimozide—Mental disorder—Methotrexate—esophageal cancer	0.000209	0.00515	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000208	0.00511	CcSEcCtD
Pimozide—Insomnia—Capecitabine—esophageal cancer	0.000206	0.00508	CcSEcCtD
Pimozide—Decreased appetite—Capecitabine—esophageal cancer	0.000198	0.00488	CcSEcCtD
Pimozide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000197	0.00484	CcSEcCtD
Pimozide—Vomiting—Cisplatin—esophageal cancer	0.000197	0.00484	CcSEcCtD
Pimozide—Vision blurred—Methotrexate—esophageal cancer	0.000196	0.00482	CcSEcCtD
Pimozide—Rash—Cisplatin—esophageal cancer	0.000195	0.0048	CcSEcCtD
Pimozide—Constipation—Capecitabine—esophageal cancer	0.000195	0.0048	CcSEcCtD
Pimozide—Dermatitis—Cisplatin—esophageal cancer	0.000195	0.0048	CcSEcCtD
Pimozide—Anaemia—Methotrexate—esophageal cancer	0.000192	0.00473	CcSEcCtD
Pimozide—Leukopenia—Methotrexate—esophageal cancer	0.000186	0.00458	CcSEcCtD
Pimozide—Nausea—Cisplatin—esophageal cancer	0.000184	0.00452	CcSEcCtD
Pimozide—Urticaria—Capecitabine—esophageal cancer	0.000181	0.00446	CcSEcCtD
Pimozide—Convulsion—Methotrexate—esophageal cancer	0.00018	0.00443	CcSEcCtD
Pimozide—Chest pain—Methotrexate—esophageal cancer	0.000177	0.00436	CcSEcCtD
Pimozide—Myalgia—Methotrexate—esophageal cancer	0.000177	0.00436	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000176	0.00433	CcSEcCtD
Pimozide—Nervous system disorder—Methotrexate—esophageal cancer	0.000166	0.0041	CcSEcCtD
Pimozide—Skin disorder—Methotrexate—esophageal cancer	0.000165	0.00406	CcSEcCtD
Pimozide—Hyperhidrosis—Methotrexate—esophageal cancer	0.000164	0.00404	CcSEcCtD
Pimozide—Asthenia—Capecitabine—esophageal cancer	0.000164	0.00403	CcSEcCtD
Pimozide—Anorexia—Methotrexate—esophageal cancer	0.000162	0.00398	CcSEcCtD
Pimozide—Pruritus—Capecitabine—esophageal cancer	0.000161	0.00397	CcSEcCtD
Pimozide—Hypotension—Methotrexate—esophageal cancer	0.000159	0.0039	CcSEcCtD
Pimozide—Diarrhoea—Capecitabine—esophageal cancer	0.000156	0.00384	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000155	0.00381	CcSEcCtD
Pimozide—Insomnia—Methotrexate—esophageal cancer	0.000153	0.00378	CcSEcCtD
Pimozide—Somnolence—Methotrexate—esophageal cancer	0.000151	0.00371	CcSEcCtD
Pimozide—Dizziness—Capecitabine—esophageal cancer	0.000151	0.00371	CcSEcCtD
Pimozide—Decreased appetite—Methotrexate—esophageal cancer	0.000147	0.00363	CcSEcCtD
Pimozide—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000146	0.00361	CcSEcCtD
Pimozide—Vomiting—Capecitabine—esophageal cancer	0.000145	0.00357	CcSEcCtD
Pimozide—Rash—Capecitabine—esophageal cancer	0.000144	0.00354	CcSEcCtD
Pimozide—Dermatitis—Capecitabine—esophageal cancer	0.000144	0.00353	CcSEcCtD
Pimozide—Headache—Capecitabine—esophageal cancer	0.000143	0.00352	CcSEcCtD
Pimozide—Nausea—Capecitabine—esophageal cancer	0.000135	0.00333	CcSEcCtD
Pimozide—Urticaria—Methotrexate—esophageal cancer	0.000135	0.00332	CcSEcCtD
Pimozide—Asthenia—Methotrexate—esophageal cancer	0.000122	0.003	CcSEcCtD
Pimozide—Pruritus—Methotrexate—esophageal cancer	0.00012	0.00296	CcSEcCtD
Pimozide—Diarrhoea—Methotrexate—esophageal cancer	0.000116	0.00286	CcSEcCtD
Pimozide—Dizziness—Methotrexate—esophageal cancer	0.000112	0.00276	CcSEcCtD
Pimozide—Vomiting—Methotrexate—esophageal cancer	0.000108	0.00266	CcSEcCtD
Pimozide—Rash—Methotrexate—esophageal cancer	0.000107	0.00263	CcSEcCtD
Pimozide—Dermatitis—Methotrexate—esophageal cancer	0.000107	0.00263	CcSEcCtD
Pimozide—Headache—Methotrexate—esophageal cancer	0.000106	0.00262	CcSEcCtD
Pimozide—Nausea—Methotrexate—esophageal cancer	0.000101	0.00248	CcSEcCtD
Pimozide—HRH1—Signaling Pathways—NOTCH1—esophageal cancer	1.44e-05	3.37e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.43e-05	3.35e-05	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.42e-05	3.33e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	1.42e-05	3.32e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—EP300—esophageal cancer	1.42e-05	3.31e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—ERBB2—esophageal cancer	1.41e-05	3.3e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—PIK3CA—esophageal cancer	1.41e-05	3.29e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—PIK3CA—esophageal cancer	1.41e-05	3.29e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—BCL2—esophageal cancer	1.4e-05	3.28e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—BCL2—esophageal cancer	1.4e-05	3.28e-05	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—PIK3CA—esophageal cancer	1.4e-05	3.27e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—EP300—esophageal cancer	1.39e-05	3.27e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—NOS3—esophageal cancer	1.39e-05	3.25e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.39e-05	3.25e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.38e-05	3.24e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.37e-05	3.2e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—ERBB2—esophageal cancer	1.36e-05	3.19e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—ERBB2—esophageal cancer	1.36e-05	3.19e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—NOS3—esophageal cancer	1.36e-05	3.18e-05	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—PIK3CA—esophageal cancer	1.35e-05	3.16e-05	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—PIK3CA—esophageal cancer	1.35e-05	3.16e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—NOS3—esophageal cancer	1.34e-05	3.15e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—NOS3—esophageal cancer	1.34e-05	3.15e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.34e-05	3.15e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CREBBP—esophageal cancer	1.33e-05	3.12e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HIF1A—esophageal cancer	1.33e-05	3.12e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CREBBP—esophageal cancer	1.31e-05	3.07e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—CREBBP—esophageal cancer	1.31e-05	3.06e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—EGFR—esophageal cancer	1.31e-05	3.06e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CREBBP—esophageal cancer	1.31e-05	3.06e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.31e-05	3.06e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—CREBBP—esophageal cancer	1.3e-05	3.04e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—ERBB2—esophageal cancer	1.3e-05	3.04e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CCND1—esophageal cancer	1.3e-05	3.04e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.3e-05	3.04e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ENO1—esophageal cancer	1.3e-05	3.04e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	1.29e-05	3.03e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HIF1A—esophageal cancer	1.29e-05	3.01e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HIF1A—esophageal cancer	1.29e-05	3.01e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CCND1—esophageal cancer	1.29e-05	3.01e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—EGFR—esophageal cancer	1.29e-05	3.01e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	1.29e-05	3.01e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—EGFR—esophageal cancer	1.28e-05	3.01e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PSME2—esophageal cancer	1.28e-05	2.99e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PSME1—esophageal cancer	1.28e-05	2.99e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KDR—esophageal cancer	1.27e-05	2.98e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PTGS2—esophageal cancer	1.27e-05	2.98e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	1.27e-05	2.97e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	1.26e-05	2.96e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—CREBBP—esophageal cancer	1.26e-05	2.94e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—CREBBP—esophageal cancer	1.26e-05	2.94e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—ERBB2—esophageal cancer	1.26e-05	2.94e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—ERBB2—esophageal cancer	1.26e-05	2.94e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CDKN1A—esophageal cancer	1.26e-05	2.94e-05	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.25e-05	2.93e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CDKN1A—esophageal cancer	1.25e-05	2.91e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MYC—esophageal cancer	1.23e-05	2.89e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KDR—esophageal cancer	1.23e-05	2.88e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KDR—esophageal cancer	1.23e-05	2.88e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—EP300—esophageal cancer	1.23e-05	2.88e-05	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.23e-05	2.88e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—PTGS2—esophageal cancer	1.23e-05	2.88e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—PTGS2—esophageal cancer	1.23e-05	2.88e-05	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.23e-05	2.87e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.23e-05	2.87e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MYC—esophageal cancer	1.22e-05	2.85e-05	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.21e-05	2.83e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—EGFR—esophageal cancer	1.21e-05	2.82e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—CDKN1A—esophageal cancer	1.2e-05	2.82e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.2e-05	2.82e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NOTCH1—esophageal cancer	1.2e-05	2.81e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—EP300—esophageal cancer	1.2e-05	2.8e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NOS3—esophageal cancer	1.19e-05	2.79e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—EGFR—esophageal cancer	1.19e-05	2.78e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—EP300—esophageal cancer	1.18e-05	2.77e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.18e-05	2.76e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NOS3—esophageal cancer	1.17e-05	2.74e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—NOS3—esophageal cancer	1.17e-05	2.74e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NOS3—esophageal cancer	1.17e-05	2.74e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—NOS3—esophageal cancer	1.17e-05	2.74e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—CDKN1A—esophageal cancer	1.16e-05	2.73e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—CDKN1A—esophageal cancer	1.16e-05	2.73e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—NOS3—esophageal cancer	1.16e-05	2.73e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NOTCH1—esophageal cancer	1.16e-05	2.72e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NOTCH1—esophageal cancer	1.16e-05	2.72e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NOS3—esophageal cancer	1.15e-05	2.7e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—EP300—esophageal cancer	1.15e-05	2.68e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.14e-05	2.67e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	1.14e-05	2.66e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—NOS3—esophageal cancer	1.13e-05	2.64e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—NOS3—esophageal cancer	1.13e-05	2.64e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CCND1—esophageal cancer	1.12e-05	2.63e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—PIK3CA—esophageal cancer	1.12e-05	2.61e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—ERBB2—esophageal cancer	1.11e-05	2.61e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—PIK3CA—esophageal cancer	1.11e-05	2.61e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—CDKN1A—esophageal cancer	1.11e-05	2.6e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—EP300—esophageal cancer	1.11e-05	2.59e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—EP300—esophageal cancer	1.11e-05	2.59e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.1e-05	2.58e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—ERBB2—esophageal cancer	1.1e-05	2.57e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	1.1e-05	2.57e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—ERBB2—esophageal cancer	1.09e-05	2.56e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CREBBP—esophageal cancer	1.09e-05	2.54e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	1.09e-05	2.54e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	1.08e-05	2.52e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—CDKN1A—esophageal cancer	1.08e-05	2.52e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—CDKN1A—esophageal cancer	1.08e-05	2.52e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTGS2—esophageal cancer	1.07e-05	2.51e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.07e-05	2.5e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—EGFR—esophageal cancer	1.07e-05	2.5e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTGS2—esophageal cancer	1.06e-05	2.49e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EP300—esophageal cancer	1.06e-05	2.48e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CREBBP—esophageal cancer	1.05e-05	2.46e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CREBBP—esophageal cancer	1.05e-05	2.46e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—PIK3CA—esophageal cancer	1.05e-05	2.45e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MYC—esophageal cancer	1.04e-05	2.44e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.04e-05	2.43e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—EGFR—esophageal cancer	1.03e-05	2.42e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—EGFR—esophageal cancer	1.03e-05	2.42e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EP300—esophageal cancer	1.03e-05	2.42e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MYC—esophageal cancer	1.03e-05	2.42e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—PIK3CA—esophageal cancer	1.03e-05	2.42e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTGS2—esophageal cancer	1.03e-05	2.41e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTGS2—esophageal cancer	1.03e-05	2.41e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EP300—esophageal cancer	1.02e-05	2.39e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EP300—esophageal cancer	1.02e-05	2.39e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—EGFR—esophageal cancer	1.02e-05	2.39e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—esophageal cancer	1.01e-05	2.37e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—EGFR—esophageal cancer	1.01e-05	2.36e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.01e-05	2.36e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—esophageal cancer	9.98e-06	2.34e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CREBBP—esophageal cancer	9.85e-06	2.31e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CCND1—esophageal cancer	9.85e-06	2.31e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—EGFR—esophageal cancer	9.76e-06	2.28e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NOS3—esophageal cancer	9.73e-06	2.28e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CCND1—esophageal cancer	9.69e-06	2.27e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCND1—esophageal cancer	9.67e-06	2.26e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	9.53e-06	2.23e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCND1—esophageal cancer	9.52e-06	2.23e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—HMOX1—esophageal cancer	9.46e-06	2.22e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—EGFR—esophageal cancer	9.44e-06	2.21e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—EGFR—esophageal cancer	9.44e-06	2.21e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NOS3—esophageal cancer	9.42e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NOS3—esophageal cancer	9.42e-06	2.2e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CDKN1A—esophageal cancer	9.38e-06	2.19e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CDKN1A—esophageal cancer	9.35e-06	2.19e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CREBBP—esophageal cancer	9.29e-06	2.17e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—PIK3CA—esophageal cancer	9.27e-06	2.17e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MYC—esophageal cancer	9.21e-06	2.16e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	9.2e-06	2.15e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ERBB2—esophageal cancer	9.11e-06	2.13e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—PIK3CA—esophageal cancer	9.1e-06	2.13e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ABCB1—esophageal cancer	9.08e-06	2.13e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EP300—esophageal cancer	9.07e-06	2.12e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—NOS3—esophageal cancer	9.04e-06	2.12e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—esophageal cancer	9.01e-06	2.11e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—esophageal cancer	9e-06	2.11e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—PIK3CA—esophageal cancer	8.97e-06	2.1e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—PIK3CA—esophageal cancer	8.97e-06	2.1e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EP300—esophageal cancer	8.92e-06	2.09e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—esophageal cancer	8.91e-06	2.09e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—esophageal cancer	8.91e-06	2.09e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—EP300—esophageal cancer	8.91e-06	2.09e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EP300—esophageal cancer	8.9e-06	2.08e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.9e-06	2.08e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—EP300—esophageal cancer	8.89e-06	2.08e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—EP300—esophageal cancer	8.86e-06	2.07e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PIK3CA—esophageal cancer	8.85e-06	2.07e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—NOS3—esophageal cancer	8.82e-06	2.07e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ERBB2—esophageal cancer	8.81e-06	2.06e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ERBB2—esophageal cancer	8.81e-06	2.06e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—esophageal cancer	8.8e-06	2.06e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PIK3CA—esophageal cancer	8.76e-06	2.05e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EP300—esophageal cancer	8.76e-06	2.05e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—esophageal cancer	8.72e-06	2.04e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—esophageal cancer	8.72e-06	2.04e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—EP300—esophageal cancer	8.57e-06	2.01e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—EP300—esophageal cancer	8.57e-06	2.01e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—esophageal cancer	8.56e-06	2e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—esophageal cancer	8.48e-06	1.98e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—PIK3CA—esophageal cancer	8.47e-06	1.98e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—NOS3—esophageal cancer	8.31e-06	1.95e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—esophageal cancer	8.27e-06	1.94e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—PIK3CA—esophageal cancer	8.2e-06	1.92e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—PIK3CA—esophageal cancer	8.2e-06	1.92e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—esophageal cancer	8.07e-06	1.89e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—esophageal cancer	8.04e-06	1.88e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—esophageal cancer	7.9e-06	1.85e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CREBBP—esophageal cancer	7.87e-06	1.84e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PIK3CA—esophageal cancer	7.82e-06	1.83e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1A—esophageal cancer	7.78e-06	1.82e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—esophageal cancer	7.78e-06	1.82e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—esophageal cancer	7.78e-06	1.82e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—esophageal cancer	7.77e-06	1.82e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—esophageal cancer	7.76e-06	1.82e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—esophageal cancer	7.73e-06	1.81e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	7.64e-06	1.79e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—esophageal cancer	7.63e-06	1.79e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—esophageal cancer	7.6e-06	1.78e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—esophageal cancer	7.6e-06	1.78e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—esophageal cancer	7.59e-06	1.78e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—PIK3CA—esophageal cancer	7.57e-06	1.77e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—PIK3CA—esophageal cancer	7.57e-06	1.77e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1A—esophageal cancer	7.53e-06	1.76e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1A—esophageal cancer	7.53e-06	1.76e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—esophageal cancer	7.47e-06	1.75e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EP300—esophageal cancer	7.41e-06	1.73e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—esophageal cancer	7.39e-06	1.73e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EP300—esophageal cancer	7.16e-06	1.68e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EP300—esophageal cancer	7.16e-06	1.68e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—NOS3—esophageal cancer	7.04e-06	1.65e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—EP300—esophageal cancer	6.88e-06	1.61e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—EP300—esophageal cancer	6.71e-06	1.57e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	6.71e-06	1.57e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PIK3CA—esophageal cancer	6.6e-06	1.54e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PIK3CA—esophageal cancer	6.59e-06	1.54e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PIK3CA—esophageal cancer	6.58e-06	1.54e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PIK3CA—esophageal cancer	6.58e-06	1.54e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PIK3CA—esophageal cancer	6.55e-06	1.53e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—esophageal cancer	6.49e-06	1.52e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	6.48e-06	1.52e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—esophageal cancer	6.45e-06	1.51e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—esophageal cancer	6.44e-06	1.51e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—esophageal cancer	6.38e-06	1.49e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—esophageal cancer	6.37e-06	1.49e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CA—esophageal cancer	6.34e-06	1.48e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CA—esophageal cancer	6.34e-06	1.48e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—EP300—esophageal cancer	6.32e-06	1.48e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—esophageal cancer	6.31e-06	1.48e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—esophageal cancer	6.27e-06	1.47e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—esophageal cancer	6.24e-06	1.46e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—esophageal cancer	6.24e-06	1.46e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—esophageal cancer	6.11e-06	1.43e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—esophageal cancer	6.11e-06	1.43e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CREBBP—esophageal cancer	6.07e-06	1.42e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CA—esophageal cancer	5.48e-06	1.28e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—NOS3—esophageal cancer	5.44e-06	1.27e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—EP300—esophageal cancer	5.36e-06	1.25e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—esophageal cancer	5.3e-06	1.24e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CA—esophageal cancer	5.3e-06	1.24e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CA—esophageal cancer	5.3e-06	1.24e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—esophageal cancer	5.13e-06	1.2e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—esophageal cancer	5.13e-06	1.2e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CA—esophageal cancer	5.09e-06	1.19e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.97e-06	1.16e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.96e-06	1.16e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CA—esophageal cancer	4.68e-06	1.1e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—EP300—esophageal cancer	4.13e-06	9.68e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.96e-06	9.28e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.06e-06	7.16e-06	CbGpPWpGaD
